News & Events

News

Our latest Press Releases

Tubulis partners TUB-010 its CD30-targeting IND-ready ADC with Oncoteq

November 27, 2023

Tubulis publishes article in Molecular Cancer Therapeutics on advantages of its proprietary P5/Tubutecan platform

October 17, 2023

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients

April 20, 2023

EVENTS

Meet Tubulis live

Presentation, Talk

ADC Linker & Conjugation Summit, Boston

August 22 – August 24

Festival of Biologics, Basel

October 10 – October 12

World ADC, San Diego

October 16 – October 19

ESMO Congress, Madrid

October 20 – October 24

Bio Europe, Munich

November 6 – November 8

J.P. Morgan 42nd Conference, San Francisco

January 8 – January 11